On 19 December 2016, the European Medicines Agency (“EMA”) published an updated version of the EMA guidance document concerning post-authorisation procedural advice for users of ...24 January 2017
Webinar | Generic Drug Labeling, Product Liability, and the Changing FDA Regulatory Landscape
The webinar will take place Tuesday, March 11, 2014 at 2:00 p.m. ET.
Pending CLE certification:
This program is pending approval for CLE credit in New York and California. For all other jurisdictions, attendees will receive a Uniform Certificate of Attendance.
Note to NY Lawyers:
This program is appropriate for non-transitional lawyers, but not acceptable for newly admitted lawyers.
For any questions regarding this event, please contact Kristen Walker.
For the latest government regulatory developments please visit us at Focus on Regulation at www.hlregulation.com
Regulation (EU) No 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (“the Clinical Trials Regulation”) was...24 January 2017
The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published a draft strategy for developing pharmacopoeial public quality standards for biological...20 January 2017